Pediatrix Medical Group, Inc. (NYSE:MD) Shares Acquired by Parkside Financial Bank & Trust

Parkside Financial Bank & Trust raised its position in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 36.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,919 shares of the company’s stock after purchasing an additional 1,040 shares during the period. Parkside Financial Bank & Trust’s holdings in Pediatrix Medical Group were worth $51,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Proficio Capital Partners LLC acquired a new position in Pediatrix Medical Group during the 4th quarter worth $404,000. Illinois Municipal Retirement Fund increased its holdings in shares of Pediatrix Medical Group by 7.8% during the fourth quarter. Illinois Municipal Retirement Fund now owns 47,409 shares of the company’s stock valued at $622,000 after purchasing an additional 3,411 shares during the period. Ieq Capital LLC raised its stake in shares of Pediatrix Medical Group by 47.9% during the fourth quarter. Ieq Capital LLC now owns 40,850 shares of the company’s stock valued at $536,000 after purchasing an additional 13,233 shares in the last quarter. New York State Common Retirement Fund lifted its holdings in Pediatrix Medical Group by 9.1% in the fourth quarter. New York State Common Retirement Fund now owns 61,211 shares of the company’s stock worth $803,000 after purchasing an additional 5,126 shares during the period. Finally, Principal Financial Group Inc. grew its position in Pediatrix Medical Group by 7.5% in the 4th quarter. Principal Financial Group Inc. now owns 551,924 shares of the company’s stock valued at $7,241,000 after buying an additional 38,306 shares in the last quarter. 97.71% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts have commented on MD shares. UBS Group boosted their price target on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a research report on Friday, February 21st. Mizuho boosted their target price on Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a report on Tuesday, November 19th. Deutsche Bank Aktiengesellschaft increased their price target on Pediatrix Medical Group from $9.00 to $15.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Macquarie began coverage on Pediatrix Medical Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $18.00 price objective on the stock. Finally, StockNews.com raised Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $17.08.

Pediatrix Medical Group Price Performance

Shares of NYSE:MD opened at $14.46 on Tuesday. The company has a market capitalization of $1.24 billion, a PE ratio of -12.05, a price-to-earnings-growth ratio of 1.74 and a beta of 1.57. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60. The stock has a fifty day moving average of $13.99 and a 200-day moving average of $13.19. Pediatrix Medical Group, Inc. has a one year low of $6.62 and a one year high of $17.67.

Pediatrix Medical Group (NYSE:MD) last announced its earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.37 by $0.12. The business had revenue of $502.36 million during the quarter, compared to the consensus estimate of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. As a group, equities analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.